BofA lowered the firm’s price target on Corebridge (CRBG) to $39 from $40 and keeps a Buy rating on the shares. The firm is updating its price targets for U.S. Insurance companies under its coverage, the analyst tells investors. Q3 turned out to be a “relatively calm” season without any hurricanes making landfall in the U.S. and, while 1H saw elevated levels of macro uncertainties, this did not translate to material adverse impact on earnings, the firm says.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBG:
- Corebridge initiated with a Peer Perform at Wolfe Research
- Corebridge price target lowered to $38 from $39 at Evercore ISI
- 3 Best Stocks to Buy Now, 10/9/2025, According to Top Analysts
- Corebridge price target lowered to $41 from $42 at Keefe Bruyette
- Corebridge price target lowered to $39 from $46 at Barclays